Breaking into Longevity Biotech - Mixer
Longevity has science, capital, and attention. What's not as clear are the paths for entry in... For the postdoc or AI researcher wanting to work on aging, or for the pharma team that wants to run an aging-relevant trial?
Join Norn Group and age1 during Boston's Longevity Week for conversation on how our panelists got in, what they look for in people, and what it takes to make aging a serious therapeutic area for the drug development ecosystem.
Panel:
Jack O'Meara (Aerska)
Andrew Brack (ARPA-H)
James Peyer (Cambrian Bio)
Michael Cooney (Bain Capital)
Satvik Dasariraju (age1)
Moderated by Sufal Deb (Norn Group)
Schedule:
12:00pm: Doors, coffee, networking
12:45pm: Panel + audience Q&A
1:30pm: Open networking
3:00pm: Close
Capacity is limited, and registration is approval-based. Please answer the short questions when signing up.